Daniel Kwin Grauer - Net Worth and Insider Trading
Daniel Kwin Grauer Net Worth
The estimated net worth of Daniel Kwin Grauer is at least $5,900 dollars as of 2024-11-13. Daniel Kwin Grauer is the Director of Defence Therapeutics Inc and owns about 10,000 shares of Defence Therapeutics Inc (XCNQ:DTC) stock worth over $5,900. Details can be seen in Daniel Kwin Grauer's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Daniel Kwin Grauer has not made any transactions after 2023-07-24 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Daniel Kwin Grauer
Daniel Kwin Grauer Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Daniel Kwin Grauer owns 1 companies in total, including Defence Therapeutics Inc (XCNQ:DTC) .
Click here to see the complete history of Daniel Kwin Grauer’s form 4 insider trades.
Insider Ownership Summary of Daniel Kwin Grauer
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| XCNQ:DTC | Defence Therapeutics Inc | 2023-07-24 | Director |
Daniel Kwin Grauer Latest Holdings Summary
Daniel Kwin Grauer currently owns a total of 1 stock. Daniel Kwin Grauer owns 10,000 shares of Defence Therapeutics Inc (XCNQ:DTC) as of July 24, 2023, with a value of $5,900.
Latest Holdings of Daniel Kwin Grauer
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| XCNQ:DTC | Defence Therapeutics Inc | 2023-07-24 | 10,000 | 0.59 | 5,900 |
Holding Weightings of Daniel Kwin Grauer
Daniel Kwin Grauer Form 4 Trading Tracker
According to the SEC Form 4 filings, Daniel Kwin Grauer has made a total of 4 transactions in Defence Therapeutics Inc (XCNQ:DTC) over the past 5 years, including 4 buys and 0 sells. The most-recent trade in Defence Therapeutics Inc is the acquisition of 2,500 shares on July 24, 2023, which cost Daniel Kwin Grauer around $7,000.
Insider Trading History of Daniel Kwin Grauer
- 1
Daniel Kwin Grauer Trading Performance
GuruFocus tracks the stock performance after each of Daniel Kwin Grauer's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Daniel Kwin Grauer is -11.28%. GuruFocus also compares Daniel Kwin Grauer's trading performance to market benchmark return within the same time period. The performance of stocks bought by Daniel Kwin Grauer within 3 months outperforms 1 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Daniel Kwin Grauer's insider trading performs compared to the benchmark.
Performance of Daniel Kwin Grauer
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -7.87 | | | | | |
| Relative Return to S&P 500(%) | -9.69 | | | | | |
Daniel Kwin Grauer Ownership Network
Ownership Network List of Daniel Kwin Grauer
Ownership Network Relation of Daniel Kwin Grauer
Daniel Kwin Grauer Owned Company Details
What does Defence Therapeutics Inc do?
Who are the key executives at Defence Therapeutics Inc?
Daniel Kwin Grauer is the Director of Defence Therapeutics Inc. Other key executives at Defence Therapeutics Inc include and Director & Senior Officer Patrick Joseph Meagher .
Defence Therapeutics Inc (XCNQ:DTC) Insider Trades Summary
Over the past 18 months, Daniel Kwin Grauer made 1 insider transaction in Defence Therapeutics Inc (XCNQ:DTC) with a net purchase of 2,500. Other recent insider transactions involving Defence Therapeutics Inc (XCNQ:DTC) include a net sale of 8,000 shares made by Sarkis Meterissian , a net purchase of 2,500 shares made by Patrick Joseph Meagher ,
In summary, during the past 3 months, insiders sold 0 shares of Defence Therapeutics Inc (XCNQ:DTC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 8,000 shares of Defence Therapeutics Inc (XCNQ:DTC) were sold and 5,000 shares were bought by its insiders, resulting in a net sale of 3,000 shares.
Defence Therapeutics Inc (XCNQ:DTC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Defence Therapeutics Inc Insider Transactions
Daniel Kwin Grauer Mailing Address
Above is the net worth, insider trading, and ownership report for Daniel Kwin Grauer. Currently GuruFocus does not have mailing address information for Daniel Kwin Grauer.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
